SCHEMBL31111409

SCHEMBL31111409

CC(=O)Nc1cc(Cl)cc(N2CCOCC2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 7/20 0.59
ADORA1 P30542 6/20 0.59
KMT2A Q03164 3/20 0.52
THRB P10828 2/20 0.52
MEN1 O00255 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
GAA P10253 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KIF18A Q8NI77 2/20 0.50
PIK3R1 P27986 2/20 0.48
KCNH2 Q12809 1/20 0.44
PIK3CA P42336 3/20 0.44
MAPT P10636 2/20 0.44
PIK3CD O00329 1/20 0.44
AKT1 P31749 1/20 0.44
PIK3CB P42338 1/20 0.44
PIK3CG P48736 1/20 0.44
MTOR P42345 1/20 0.44
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23275363 1.00 ADORA2A (0.59) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL23299959 0.85 ADORA2A (0.63) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL29762385 0.84 ADORA2A (0.59) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL23274769 0.84 ADORA2A (0.59) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL23854549 0.83 KIF18A (0.52) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL24766030 0.79 KMT2A (0.47) ADORA2AADORA1KMT2ATHRBMEN1
SCHEMBL29762583 0.78 MTOR (0.47) KMT2ATHRBMEN1KDM4EALDH1A1
SCHEMBL23275235 0.78 MTOR (0.47) KMT2ATHRBMEN1KDM4EALDH1A1
SCHEMBL28602296 0.78 RAB9A (0.54) THRBKDM4EALDH1A1GAASMN1; SMN2
SCHEMBL23299970 0.78 KMT2A (0.52) KMT2AMEN1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114845711-B Inhibitors of RAF kinase 皮埃尔法布雷医药公司 2024-10-01 CN disclosed